Skip to main content
OpenTrials
Completed

NCT Number: NCT00348465

Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds

The size of the prostate changes due to insertion of the radioactive seeds. We will measure the prostate size, before and after the procedure.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The prostate size will be measured using the TRUS and CT scan on days -1, 0, 1, 9, 30, and 60 days after the brachytherapy procedure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathologically confirmed diagnosis of prostate cancer
  • T1-3 disease
  • PSA <20 ng/ml
  • Patient must sign a study-specific informed consent prior to enrollment.

Exclusion criteria

  • Patients ineligible to brachytherapy

Treatment and study plan

Brachytherapy with Iodine-125 seeds

Procedure

Brachytherapy of the prostate, and measurements of the prostate volume using CT scan and TURS

Other names: Prostate Volume over time

Sponsors and collaborators

Lead sponsor

New York Presbyterian Brooklyn Methodist Hospital

Other

Registry information

Official study title

An Observational Study to Evaluate the Changes in Prostate Volume Over Time With The Use of Transrectal Ultrasound and Computed Tomography Following Permanent Prostate Brachytherapy With Iodine-125 Seeds.

Important dates

Study start
2006
Primary completion
2007
Study completion
2008
First posted
Jul 4, 2006
Registry last updated
Sep 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.